ARCHIVES

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007